← Eichor
Condition: Squamous Cell Carcinoma Of The Vulva Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Squamous Cell Carcinoma Of The Vulva

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
NA · 1 location(s) · British Columbia Cancer Agency · NCT05576831A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial
Phase 1 · 12 location(s) · EvolveImmune United, Inc · NCT07217171Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC
Phase 2 · 2 location(s) · The Netherlands Cancer Institute · NCT05905315Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
Phase 1/Phase 2 · 4 location(s) · Yuhan Corporation · NCT06975410Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931HRYZ-T101 Injection for HPV18 Positive Solid Tumor
Phase 1 · 1 location(s) · HRYZ Biotech Co. · NCT05952947Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar
Phase N/A · 1 location(s) · Hamilton Health Sciences Corporation · NCT06039111Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VU
Phase 2 · 1 location(s) · The Netherlands Cancer Institute · NCT04192253A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants W
Phase 1/Phase 2 · 32 location(s) · Marengo Therapeutics, Inc. · NCT05592626E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Phase 2 · 3 location(s) · Christian Hinrichs · NCT05686226E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Phase 1/Phase 2 · 2 location(s) · Christian Hinrichs · NCT05639972Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
NA · 1 location(s) · Dr. Danielle Vicus · NCT03061435Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy
Phase 2 · 1 location(s) · The Netherlands Cancer Institute · NCT04161664STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision
NA · 11 location(s) · Canadian Cancer Trials Group · NCT06358469
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.